Keep the questions that matter
Use these prompts as notes for a conversation. Keep the answers next to the exact product and care route being discussed.
- Choose the questions that fit your concern.
- Leave space for the answer in your own words.
- Keep the question open if the answer is unclear.
Ask about the care decision
Name the concern that brought you to the discussion. A preselected treatment is not needed to open that conversation. Ask the clinician assessing your health, whether a doctor or another professional, to describe what they need to learn and how the proposed visit will help them learn it.
- What would this assessment need to find out?
- What could make an in-person visit necessary?
- Who reads the information I send?
- How can I ask something that is not on the form?
Prescribing from a treatment-menu selection alone falls short of care standards, according to national medical-board guidance adopted in May 2026.
These national recommendations help describe a care process, while each state’s rules still govern. Ask what license or other state permission allows the health professional to see you where you will be sitting.
Ask about the proposed product
The exact product
Write down the medicine’s full name as it is given to you. Keep a separate space for the ingredient and the product form, such as an injection or a tablet. If the name is unfamiliar, ask the clinician to write it and explain why that particular product is being considered.
- Which exact medicine are we discussing?
- What is it meant to help with in my case?
- What alternatives are part of the discussion?
- If it is custom-prepared, what change is being made for me?
Compounding means mixing or changing a medicine for a person’s specific need.
Custom preparations
Compounded drugs had no approval from the federal Food and Drug Administration (FDA) in September 2026, even if a manufactured drug used the same ingredient.
A compounded medicine is prepared to address a specific need. Keep the product approval question separate from a general statement about a familiar ingredient.
Ask about the people handling the prescription
- Which pharmacy will fill or prepare it?
- How can I speak with the pharmacist?
- Who answers questions about the care plan?
- How will my existing clinician receive the records?
An online care service may leave the drug’s actual compounder unclear to the person receiving it, FDA notes.
That makes the pharmacy name a useful answer to keep, rather than a small detail to leave for later. Ask whether the pharmacy changes from one fill to another and how you would be told. Then use the name for the state-record check.
FDA’s BeSafeRx resource links readers to state pharmacy license databases: searchable collections of license records.
Ask about the whole bill and the next conversation
- Which charges are for the visit and which are for medicine?
- What tests or ongoing fees are outside this estimate?
- What happens to charges if treatment is not prescribed?
- How does the plan end, and what happens at renewal?
Keep a final space for the next point of contact. Ask how to share a change in your health, where product questions go and what to do if the service cannot assess a concern remotely. Read the response plan back in your own words if that helps make it clear.
You can bring these questions to a local discussion or a remote one. Pick the points you still need answered instead of trying to complete a form perfectly. The comparison is useful when it makes the next care conversation easier to have.
Compare the charges